VIVUS, Inc.
(NASDAQ : VVUS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
Loading VVUS News...
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SHPGShire PLC Sponsored ADR
-0.50%176.960.4%$170.90m
PRGOPerrigo Co. Plc
-0.03%73.996.4%$144.57m
VRXValeant Pharmaceuticals International, Inc.
-1.39%9.2514.2%$140.56m
ALRAlere Inc.
0.12%49.162.7%$137.07m
UTHRUnited Therapeutics Corporation
4.32%125.7013.9%$97.54m
JAZZJazz Pharmaceuticals Plc
-1.69%159.282.2%$89.92m
MDCOMedicines Company
1.52%49.3222.5%$75.86m
ENDPEndo International Plc
0.80%11.378.9%$73.90m
MNKMallinckrodt Plc
1.16%46.9216.8%$69.52m
HZNPHorizon Pharma plc
-0.71%15.387.6%$41.04m
ICLRICON Plc
1.59%84.494.1%$35.05m
ICPTIntercept Pharmaceuticals, Inc.
-0.78%112.3522.3%$34.59m
PRXLPAREXEL International Corporation
0.73%63.837.9%$33.77m
PCRXPacira Pharmaceuticals, Inc.
1.04%48.5510.9%$31.50m
GWPHGW Pharmaceuticals PLC Sponsored ADR
0.25%118.737.6%$28.29m

Company Profile

VIVUS, Inc. operates as a biopharmaceutical company engages in the development and commercialization of novel therapeutic products. It offers the Qsymia for chronic weight management, as well as STENDRA and SPEDRA for erectile dysfunction. Its development also include Tacrolimus which is for the treatment of Pulmonary Arterial Hypertension. The company was founded by Virgil A. Place on April 16, 1991 and is headquartered in Mountain View, CA.